08/20/2026
What does it take to turn transformative medical technology into strategic value?
On September 22, Mevion President and CEO Dr. Tina Yu will join Rajit Kamal of Medtronic and moderator Alex Herzlinger for a Harvard Business School Healthcare Alumni Association roundtable exploring how healthcare leaders translate differentiated, capital-intensive technologies into adoption and growth.
Using proton therapy and surgical robotics as examples, the conversation will explore an increasingly important question for healthcare: how can innovation deliver not only clinical impact, but meaningful value for patients and health systems?
We are proud to see Dr. Tina Yu bring the perspective of proton therapy to this important discussion.
From Innovation to Strategic Value
September 22 | 12:00–1:00 PM EST
Register here: https://hubs.ly/Q04th9hF0
In this virtual roundtable, Rajit Kamal, Tina Yu, and Alex Herzlinger will explore how medtech leaders balance clinical efficacy, patient outcomes, quality, and cost when bringing transformative technologies to market. Using surgical robotics and proton therapy as examples, the discussion will exami...